Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F19%3AN0000053" target="_blank" >RIV/00064190:_____/19:N0000053 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/19:10395859 RIV/00669806:_____/19:10395859 RIV/00216208:11140/19:10395859

Výsledek na webu

<a href="http://dx.doi.org/" target="_blank" >http://dx.doi.org/</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.33678/cor.2019.007" target="_blank" >10.33678/cor.2019.007</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study

Popis výsledku v původním jazyce

Introduction: Secondary prevention after myocardial infarction is at least as important as treatment of the acute phase. Improved cardiovascular (CV) prevention can decisively contribute to the continuation of positive trends of CV morbidity and mortality seen in the Czech Republic in last three decades. Objectives: To determine, in patients with coronary heart disease (CHD), how the treatment goals as defined by the current European guidelines on CV secondary prevention (2012) are implemented in clinical practice. Methods: Patients <= 80 years when hospitalized for acute coronary syndrome, and/or CABG or PCI were identified from hospital records and invited to outpatient clinical investigation (interview) not less than 6 months and not more than 2 years after hospital discharge. Data collection was performed based on a review of medical records and the interview. Results: Of 624 invited patients, 406 responders were interviewed. Among these, 20% were smokers, 44.8% were obese (BMI >= 30), 85.5% were overweight or obese (BMI >= 25), 70.2% had central obesity (waist circumference >= 102 cm in men, >= 88 cm in women), the recommended level of physical activity (30 minutes 5 times a week) was not attained by 85%. Raised blood pressure (>= 140/90 mmHg, in diabetics >= 140/80 mmHg) was measured in 55.1%, elevated LDL-cholesterol (>= 1.8 mmol/L) in 63.5% of responders. Manifest diabetes mellitus (known plus newly discovered at interview) was present in 41.2%, and prediabetes in 23.4% of patients. The respective figures when using the oral glucose tolerance test (OGTT) were 44.7% and 32.3%. At interview, 88.4% of patients were being treated with aspirin or other antiplatelet drugs, 81.3% with beta-blockers, 78.8% with ACE inhibitors or angiotensin receptor blockers (ARBs), 92.1% with statins, and 92.9% had undergone revascularization. Conclusion: The majority of coronary patients have unhealthy lifestyles such as unhealthy diet and sedentary behavior. The prevalence of overweight, obesity, and diabetes is very high, and prevalence of obesity further increased. Although pharmacotherapy is used in the majority of patients, the recommended levels of blood pressure, lipid, and glucose metabolism are achieved in only a minority.

Název v anglickém jazyce

Current status of secondary prevention in Czech coronary patients in the EUROASPIRE V Study

Popis výsledku anglicky

Introduction: Secondary prevention after myocardial infarction is at least as important as treatment of the acute phase. Improved cardiovascular (CV) prevention can decisively contribute to the continuation of positive trends of CV morbidity and mortality seen in the Czech Republic in last three decades. Objectives: To determine, in patients with coronary heart disease (CHD), how the treatment goals as defined by the current European guidelines on CV secondary prevention (2012) are implemented in clinical practice. Methods: Patients <= 80 years when hospitalized for acute coronary syndrome, and/or CABG or PCI were identified from hospital records and invited to outpatient clinical investigation (interview) not less than 6 months and not more than 2 years after hospital discharge. Data collection was performed based on a review of medical records and the interview. Results: Of 624 invited patients, 406 responders were interviewed. Among these, 20% were smokers, 44.8% were obese (BMI >= 30), 85.5% were overweight or obese (BMI >= 25), 70.2% had central obesity (waist circumference >= 102 cm in men, >= 88 cm in women), the recommended level of physical activity (30 minutes 5 times a week) was not attained by 85%. Raised blood pressure (>= 140/90 mmHg, in diabetics >= 140/80 mmHg) was measured in 55.1%, elevated LDL-cholesterol (>= 1.8 mmol/L) in 63.5% of responders. Manifest diabetes mellitus (known plus newly discovered at interview) was present in 41.2%, and prediabetes in 23.4% of patients. The respective figures when using the oral glucose tolerance test (OGTT) were 44.7% and 32.3%. At interview, 88.4% of patients were being treated with aspirin or other antiplatelet drugs, 81.3% with beta-blockers, 78.8% with ACE inhibitors or angiotensin receptor blockers (ARBs), 92.1% with statins, and 92.9% had undergone revascularization. Conclusion: The majority of coronary patients have unhealthy lifestyles such as unhealthy diet and sedentary behavior. The prevalence of overweight, obesity, and diabetes is very high, and prevalence of obesity further increased. Although pharmacotherapy is used in the majority of patients, the recommended levels of blood pressure, lipid, and glucose metabolism are achieved in only a minority.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30201 - Cardiac and Cardiovascular systems

Projekt

<a href="/cs/project/NV17-29520A" target="_blank" >NV17-29520A: Dlouhodobé trendy sekundární prevence ICHS a predikce rizika ve vybraném vzorku české populace - česká část studie EURASPIRE V</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

COR ET VASA

ISSN

0010-8650

e-ISSN

1803-7712

Svazek periodika

61

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

7

Strana od-do

277-283

Kód UT WoS článku

000472526800003

EID výsledku v databázi Scopus

2-s2.0-85068486103